MetaCap

Attovia Therapeutics (ATTO) vs Iambic Therapeutics (IAM)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Attovia Therapeutics is the larger company by market cap ($690.3 million vs $621.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ATTO+2.17%IAM-30.67%
+30%-10%-50%
Oct 15, 20261 yearNov 20, 2026
ATTO+9.98%IAM-44.94%
+15%-23%-61%
Oct 12, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ATTO versus IAM key metrics
MetricATTOIAM
Share price$15.10$13.11
Market cap$690.26M$621.42M
1-day change-3.08%-8.06%
EPS (TTM)$-5.53$-2.69
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
52-week high$28.00$25.00
52-week low$12.94$9.60
Distance from 52-week high-46.07%-47.56%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+186.09%+107.86%
Average volume337.27K714.92K
Shares outstanding45.71M47.40M
Employees50171
SectorHealth CareHealth Care
IndustryBiotechnology: Biological Products (No Diagnostic Substances)Biotechnology: Biological Products (No Diagnostic Substances)

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Attovia Therapeutics

ATTO stock →

Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 50 employees

About Iambic Therapeutics

IAM stock →

Iambic Therapeutics, Inc. operates as a biotechnology company that develops therapeutics from its AI discovery platform that optimizes target product profiles and drug candidates in the United States and Internationally.

Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 171 employees

ATTO vs IAM FAQ

Which is bigger, Attovia Therapeutics or Iambic Therapeutics?

Attovia Therapeutics (ATTO) is larger, with a market capitalization of $690.26M compared with $621.42M for Iambic Therapeutics (IAM).

Are Attovia Therapeutics and Iambic Therapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.

More comparisons